Conventional treatment modalities include use of oral hypoglycemic agents, appropriate insulin delivery, nutritional planning, screening for/management of diabetes associated micro and macrovascular complications along with assessment of psychological and general wellbeing of affected individuals.
The rationale behind use of cellular therapy for diabetes is that, progenitor cells in the human body are capable of differentiating in vivo to produce beta cells,the islet cells that manufacture insulin as well as pancreatic islet cells. Cell-based approach to insulin replacement has been shown to ultimately improve glucose control in patients with both type 1 and 2 diabetes.
Our protocol involves harvesting cells from the patients own body (autologous stem cells). After activation the cells are transplanted into the appropriate site. The degree of improvement achieved will depend on the stage of the condition, presence of other influencing factors and patient compliance with respect to following diet and allied therapies (physiotherapy, yoga).